{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:38:51Z","timestamp":1778870331269,"version":"3.51.4"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008136","name":"University of Namur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008136","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.thromres.2021.05.010","type":"journal-article","created":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T07:41:16Z","timestamp":1621064476000},"page":"163-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination"],"prefix":"10.1016","volume":"203","author":[{"given":"Jonathan","family":"Douxfils","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Favresse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Dogn\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Lecompte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Susen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Cordonnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lien","family":"Lebreton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Gosselin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Si\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Pernod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Gruel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Vayne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Mullier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2021.05.010_bb0005","author":"European Medicines Agency"},{"key":"10.1016\/j.thromres.2021.05.010_bb0010","author":"European Medicines Agency"},{"key":"10.1016\/j.thromres.2021.05.010_bb0015","author":"World Health Organization"},{"key":"10.1016\/j.thromres.2021.05.010_bb0020","author":"European Medicines Agency"},{"key":"10.1016\/j.thromres.2021.05.010_bb0025","author":"European Medicines Agency"},{"key":"10.1016\/j.thromres.2021.05.010_bb0030","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2106075","article-title":"Thrombotic thrombocytopenia after Ad26.COV2.S vaccination - response from the manufacturer","author":"Sadoff","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.thromres.2021.05.010_bb0035","doi-asserted-by":"crossref","first-page":"651","DOI":"10.15585\/mmwr.mm7017e4","article-title":"Updated recommendations from the advisory committee on immunization practices for use of the Janssen (Johnson & Johnson) COVID-19 vaccine after reports of thrombosis with thrombocytopenia syndrome among vaccine recipients - United States, April 2021","volume":"70","author":"MacNeil","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.thromres.2021.05.010_bb0040","author":"Food and Drug Administration"},{"key":"10.1016\/j.thromres.2021.05.010_bb0045","author":"European Medicines Agency"},{"key":"10.1016\/j.thromres.2021.05.010_bb0050","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","author":"Greinacher","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2021.05.010_bb0055","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","author":"Schultz","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2021.05.010_bb0060","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","author":"Scully","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2021.05.010_bb0065","doi-asserted-by":"crossref","DOI":"10.1111\/jth.15347","article-title":"Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine","author":"Blauenfeldt","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.05.010_bb0070","author":"Shimabukuro"},{"key":"10.1016\/j.thromres.2021.05.010_bb0075","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2105869","article-title":"Thrombotic thrombocytopenia after Ad26.COV2.S vaccination","author":"Muir","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.thromres.2021.05.010_bb0080","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/jth.13813","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"15","author":"Greinacher","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.05.010_bb0085","series-title":"Towards Understanding ChAdOx1 nCov-19 Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT)","author":"Greinacher","year":"2021"},{"issue":"10285","key":"10.1016\/j.thromres.2021.05.010_bb0090","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S0140-6736(21)00872-2","article-title":"Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"397","author":"Bayas","year":"2021","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.thromres.2021.05.010_bb0095","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1161\/CIRCULATIONAHA.120.049015","article-title":"Heparin-induced thrombocytopenia in severe COVID-19","volume":"142","author":"Daviet","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.thromres.2021.05.010_bb0100","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s12185-020-02943-5","article-title":"Immune thrombocytopenia in a patient with COVID-19","volume":"112","author":"Deruelle","year":"2020","journal-title":"Int. J. Hematol."},{"issue":"3","key":"10.1016\/j.thromres.2021.05.010_bb0105","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.thromres.2013.06.004","article-title":"Assessment of the performances of AcuStar HIT and the combination with heparin-induced multiple electrode aggregometry: a retrospective study","volume":"132","author":"Minet","year":"2013","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2021.05.010_bb0110","article-title":"Contrast between prevalence of HIT antibodies and confirmed HIT in hospitalized COVID-19 patients: a prospective study with clinical implications","author":"Delrue","year":"2020","journal-title":"Thromb. Haemost."},{"issue":"20","key":"10.1016\/j.thromres.2021.05.010_bb0115","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1182\/blood-2008-10-186064","article-title":"Studies of the immune response in heparin-induced thrombocytopenia","volume":"113","author":"Warkentin","year":"2009","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.thromres.2021.05.010_bb0120","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1182\/blood-2014-04-566836","article-title":"Me or not me? The danger of spontaneity","volume":"123","author":"Greinacher","year":"2014","journal-title":"Blood"},{"issue":"Suppl 1(S1)","key":"10.1016\/j.thromres.2021.05.010_bb0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/ijlh.12993","article-title":"Laboratory diagnosis of heparin-induced thrombocytopenia","volume":"41","author":"Warkentin","year":"2019","journal-title":"Int. J. Lab. Hematol."},{"issue":"9","key":"10.1016\/j.thromres.2021.05.010_bb0130","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1111\/j.1538-7836.2010.03974.x","article-title":"Heparin-induced thrombocytopenia: towards standardization of platelet factor 4\/heparin antigen tests","volume":"8","author":"Greinacher","year":"2010","journal-title":"J. Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2021.05.010_bb0135","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1021\/acs.jpcb.9b11695","article-title":"Physicochemical characteristics of platelet factor 4 under various conditions are relevant for heparin-induced thrombocytopenia testing","volume":"124","author":"Bui","year":"2020","journal-title":"J. Phys. Chem. B"},{"issue":"5","key":"10.1016\/j.thromres.2021.05.010_bb0140","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/jth.15262","article-title":"COVID-19 patients often show high-titer non-platelet-activating anti-PF4\/heparin IgG antibodies","volume":"19","author":"Brodard","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"Supplement 1","key":"10.1016\/j.thromres.2021.05.010_bb0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2020-134702","article-title":"Heparin induced thrombocytopenia in patients with COVID-19","volume":"136","author":"Warrior","year":"2020","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2021.05.010_bb0150","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/jth.15283","article-title":"Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia","volume":"19","author":"Nazy","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"18","key":"10.1016\/j.thromres.2021.05.010_bb0155","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1182\/blood-2013-07-515536","article-title":"Influenza virus H1N1 activates platelets through FcgammaRIIA signaling and thrombin generation","volume":"123","author":"Boilard","year":"2014","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.thromres.2021.05.010_bb0160","doi-asserted-by":"crossref","first-page":"10930","DOI":"10.1021\/acs.analchem.0c02449","article-title":"The utility of native MS for understanding the mechanism of action of repurposed therapeutics in COVID-19: heparin as a disruptor of the SARS-CoV-2 interaction with its host cell receptor","volume":"92","author":"Yang","year":"2020","journal-title":"Anal. Chem."},{"issue":"10","key":"10.1016\/j.thromres.2021.05.010_bb0165","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/01.ATV.0000238350.89477.88","article-title":"Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies","volume":"26","author":"Greinacher","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.thromres.2021.05.010_bb0170","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.thromres.2013.12.009","article-title":"Platelet microparticle generation assay: a valuable test for immune heparin-induced thrombocytopenia diagnosis","volume":"133","author":"Mullier","year":"2014","journal-title":"Thromb. Res."},{"issue":"7","key":"10.1016\/j.thromres.2021.05.010_bb0175","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.amjmed.2008.03.012","article-title":"A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia","volume":"121","author":"Warkentin","year":"2008","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.thromres.2021.05.010_bb0180","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1182\/blood-2010-08-301424","article-title":"Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia","volume":"117","author":"Krauel","year":"2011","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.thromres.2021.05.010_bb0185","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1182\/blood-2014-01-549741","article-title":"Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder","volume":"123","author":"Warkentin","year":"2014","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.thromres.2021.05.010_bb0190","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1538-7836.2008.03040.x","article-title":"Fatal heparin-induced thrombocytopenia (HIT) during warfarin thromboprophylaxis following orthopedic surgery: another example of \u2018spontaneous\u2019 HIT?","volume":"6","author":"Jay","year":"2008","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2021.05.010_bb0195","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1538-7836.2008.03263.x","article-title":"Heparin-induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery \u2018spontaneous\u2019 HIT","volume":"7","author":"Pruthi","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.05.010_bb0200","first-page":"1","article-title":"Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty","author":"Hwang","year":"2020","journal-title":"Platelets"},{"issue":"6","key":"10.1016\/j.thromres.2021.05.010_bb0205","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3109\/09537104.2014.979338","article-title":"Spontaneous heparin-induced thrombocytopenia syndrome without any proximate heparin exposure, infection, or inflammatory condition: atypical clinical features with heparin-dependent platelet activating antibodies","volume":"26","author":"Okata","year":"2015","journal-title":"Platelets"},{"issue":"6","key":"10.1016\/j.thromres.2021.05.010_bb0210","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/09537104.2017.1366973","article-title":"Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review","volume":"28","author":"Poudel","year":"2017","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.thromres.2021.05.010_bb0215","doi-asserted-by":"crossref","first-page":"14945","DOI":"10.1038\/ncomms14945","article-title":"Anti-platelet factor 4\/polyanion antibodies mediate a new mechanism of autoimmunity","volume":"8","author":"Nguyen","year":"2017","journal-title":"Nat. Commun."},{"issue":"19","key":"10.1016\/j.thromres.2021.05.010_bb0220","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1161\/01.CIR.99.19.2530","article-title":"Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin\u202f: clinical implications for heparin-induced thrombocytopenia","volume":"99","author":"Pouplard","year":"1999","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.thromres.2021.05.010_bb0225","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1182\/blood-2012-06-434985","article-title":"Platelet factor 4 binding to lipid A of Gram-negative bacteria exposes PF4\/heparin-like epitopes","volume":"120","author":"Krauel","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2021.05.010_bb0230","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood-2013-01-478966","article-title":"Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4","volume":"122","author":"Jaax","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2021.05.010_bb0235","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1038\/ncomms9277","article-title":"Atomic description of the immune complex involved in heparin-induced thrombocytopenia","volume":"6","author":"Cai","year":"2015","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.thromres.2021.05.010_bb0240","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1182\/blood.V99.4.1230","article-title":"Defining a second epitope for heparin-induced thrombocytopenia\/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody","volume":"99","author":"Li","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2021.05.010_bb0245","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jth.14369","article-title":"Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia","volume":"17","author":"Huynh","year":"2019","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2021.05.010_bb0250","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0049-3848(00)00311-X","article-title":"Very low platelet counts in post-transfusion purpura falsely diagnosed as heparin-induced thrombocytopenia","volume":"100","author":"Lubenow","year":"2000","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2021.05.010_bb0255","doi-asserted-by":"crossref","DOI":"10.1111\/jth.15348","article-title":"Post adenoviral-based COVID-19 vaccines thrombosis: a proposed mechanism","author":"Kadkhoda","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.05.010_bb0260","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2021.7517","article-title":"US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021","author":"See","year":"2021","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.thromres.2021.05.010_bb0265","first-page":"e91","article-title":"The role of serology for COVID-19 control: population, kinetics and test performance do matter","volume":"81","author":"Tre-Hardy","year":"2020","journal-title":"J. Inf. Secur."},{"issue":"3","key":"10.1016\/j.thromres.2021.05.010_bb0270","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1182\/blood-2014-09-598029","article-title":"Dengue virus binding and replication by platelets","volume":"126","author":"Simon","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2021.05.010_bb0275","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/s41467-019-09607-x","article-title":"The role of platelets in mediating a response to human influenza infection","volume":"10","author":"Koupenova","year":"2019","journal-title":"Nat. Commun."},{"issue":"535","key":"10.1016\/j.thromres.2021.05.010_bb0280","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat6263","article-title":"Platelets from HIV-infected individuals on antiretroviral drug therapy with poor CD4(+) T cell recovery can harbor replication-competent HIV despite viral suppression","volume":"12","author":"Real","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.thromres.2021.05.010_bb0285","series-title":"Platelets in Thrombotic and Non-thrombotic Disorders","first-page":"1085","article-title":"Virus\u2013platelet associations","author":"Pryzdial","year":"2017"},{"issue":"11","key":"10.1016\/j.thromres.2021.05.010_bb0290","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in patients with COVID-19","volume":"136","author":"Manne","year":"2020","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.thromres.2021.05.010_bb0295","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/CIRCRESAHA.120.317703","article-title":"Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19","volume":"127","author":"Zaid","year":"2020","journal-title":"Circ Res."},{"issue":"1","key":"10.1016\/j.thromres.2021.05.010_bb0300","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13045-020-00954-7","article-title":"SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.thromres.2021.05.010_bb0305","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/09537104.2020.1859104","article-title":"Search for SARS-CoV-2 RNA in platelets from COVID-19 patients","volume":"32","author":"Bury","year":"2021","journal-title":"Platelets"},{"issue":"8","key":"10.1016\/j.thromres.2021.05.010_bb0310","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood.2020008762","article-title":"Antibody-induced procoagulant platelets in severe COVID-19 infection","volume":"137","author":"Althaus","year":"2021","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.thromres.2021.05.010_bb0315","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/infdis\/jis180","article-title":"Platelet apoptosis and apoptotic platelet clearance by macrophages in secondary dengue virus infections","volume":"205","author":"Alonzo","year":"2012","journal-title":"J. Infect. Dis."},{"issue":"23","key":"10.1016\/j.thromres.2021.05.010_bb0320","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/bloodadvances.2019000617","article-title":"Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcgammaRIIA): a new option in HIT?","volume":"3","author":"Goldmann","year":"2019","journal-title":"Blood Adv."},{"issue":"10","key":"10.1016\/j.thromres.2021.05.010_bb0325","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/j.1538-7836.2011.04470.x","article-title":"The Syk-kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin-PF4 complex directed antibodies","volume":"9","author":"Lhermusier","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.05.010_bb0330","article-title":"Vaccine-induced immune thrombotic thrombocytopenia (VITT): targeting pathomechanisms with Bruton tyrosine kinase inhibitors","author":"von Hundelshausen","year":"2021","journal-title":"Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.thromres.2021.05.010_bb0335","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nrneurol.2017.104","article-title":"Cerebral venous thrombosis","volume":"13","author":"Silvis","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.thromres.2021.05.010_bb0340","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/VHRM.S197732","article-title":"Splanchnic vein thrombosis: current perspectives","volume":"15","author":"Valeriani","year":"2019","journal-title":"Vasc. Health Risk Manag."},{"issue":"11","key":"10.1016\/j.thromres.2021.05.010_bb0345","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1007\/s00705-015-2579-8","article-title":"Beyond RGD: virus interactions with integrins","volume":"160","author":"Hussein","year":"2015","journal-title":"Arch. Virol."},{"key":"10.1016\/j.thromres.2021.05.010_bb0350","doi-asserted-by":"crossref","first-page":"104759","DOI":"10.1016\/j.antiviral.2020.104759","article-title":"A potential role for integrins in host cell entry by SARS-CoV-2","volume":"177","author":"Sigrist","year":"2020","journal-title":"Antivir. Res."},{"issue":"6","key":"10.1016\/j.thromres.2021.05.010_bb0355","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/ATVBAHA.107.141515","article-title":"Platelets recruit human dendritic cells via Mac-1\/JAM-C interaction and modulate dendritic cell function in vitro","volume":"27","author":"Langer","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.thromres.2021.05.010_bb0360","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nm1317","article-title":"Platelets mediate cytotoxic T lymphocyte-induced liver damage","volume":"11","author":"Iannacone","year":"2005","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.thromres.2021.05.010_bb0365","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.4049\/jimmunol.1302318","article-title":"Characterization of platelet-monocyte complexes in HIV-1-infected individuals: possible role in HIV-associated neuroinflammation","volume":"192","author":"Singh","year":"2014","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.thromres.2021.05.010_bb0370","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1182\/blood-2006-06-032524","article-title":"Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance","volume":"109","author":"Othman","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2021.05.010_bb0375","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1046\/j.1365-2141.2003.04719.x","article-title":"Intravenous administration of replication-incompetent adenovirus to rhesus monkeys induces thrombocytopenia by increasing in vivo platelet clearance","volume":"123","author":"Wolins","year":"2003","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.thromres.2021.05.010_bb0380","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1743-422X-6-25","article-title":"Analysis of adenoviral attachment to human platelets","volume":"6","author":"Shimony","year":"2009","journal-title":"Virol. J."},{"issue":"1","key":"10.1016\/j.thromres.2021.05.010_bb0385","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/1743-422X-8-456","article-title":"Human platelets express CAR with localization at the sites of intercellular interaction","volume":"8","author":"Gupalo","year":"2011","journal-title":"Virol. J."},{"issue":"6","key":"10.1016\/j.thromres.2021.05.010_bb0390","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1473-3099(20)30019-0","article-title":"Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial","volume":"20","author":"Tapia","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"6","key":"10.1016\/j.thromres.2021.05.010_bb0395","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1473-3099(20)30016-5","article-title":"Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial","volume":"20","author":"Tapia","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"5","key":"10.1016\/j.thromres.2021.05.010_bb0400","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/jth.12178","article-title":"Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases","volume":"11","author":"Hottz","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2021.05.010_bb0405","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11302-011-9227-x","article-title":"Historical perspective on ADP-induced platelet activation","volume":"7","author":"Packham","year":"2011","journal-title":"Purinergic Signal"},{"issue":"5","key":"10.1016\/j.thromres.2021.05.010_bb0410","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/MOH.0000000000000069","article-title":"Polyphosphate: a new player in the field of hemostasis","volume":"21","author":"Smith","year":"2014","journal-title":"Curr. Opin. Hematol."},{"issue":"18","key":"10.1016\/j.thromres.2021.05.010_bb0415","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood-2013-11-462432","article-title":"Emerging roles for platelets as immune and inflammatory cells","volume":"123","author":"Morrell","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2021.05.010_bb0420","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1182\/bloodadvances.2016000877","article-title":"Polyphosphate\/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia","volume":"1","author":"Cines","year":"2016","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2021.05.010_bb0425","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fmed.2019.00076","article-title":"Polyphosphate as a target for interference with inflammation and thrombosis","volume":"6","author":"Mailer","year":"2019","journal-title":"Front. Med. (Lausanne)"},{"issue":"1","key":"10.1016\/j.thromres.2021.05.010_bb0430","first-page":"11","article-title":"Regulatory mechanisms, prophylaxis and treatment of vascular leakage following severe trauma and shock","volume":"4","author":"Duan","year":"2017","journal-title":"Mil. Med. Res."},{"issue":"4","key":"10.1016\/j.thromres.2021.05.010_bb0435","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1182\/blood-2013-11-539262","article-title":"Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia","volume":"127","author":"Tutwiler","year":"2016","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.thromres.2021.05.010_bb0440","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/ATVBAHA.120.315061","article-title":"Endogenous THBD (thrombomodulin) mediates angiogenesis in the ischemic brain-brief report","volume":"40","author":"Wenzel","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.thromres.2021.05.010_bb0445","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/ijms17010084","article-title":"The importance of thrombin in cerebral injury and disease","volume":"17","author":"Krenzlin","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.thromres.2021.05.010_bb0450","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/blood.V67.2.362.362","article-title":"Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain","volume":"67","author":"Ishii","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2021.05.010_bb0455","series-title":"The SARS-CoV-2 Spike Protein Disrupts the Cooperative Function of Human Cardiac Pericytes - Endothelial Cells Through CD147 Receptor-mediated Signalling: A Potential Non-infective Mechanism of COVID-19 Microvascular Disease","author":"Avolio","year":"2020"},{"key":"10.1016\/j.thromres.2021.05.010_bb0460","series-title":"Aberrant Glycosylation of Anti-SARS-CoV-2 IgG Is a Pro-thrombotic Stimulus for Platelets","author":"Bye","year":"2021"},{"issue":"6532","key":"10.1016\/j.thromres.2021.05.010_bb0465","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc8378","article-title":"Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity","volume":"371","author":"Larsen","year":"2021","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.thromres.2021.05.010_bb0470","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/jth.14850","article-title":"Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis","volume":"18","author":"Panigada","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2021.05.010_bb0475","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.thromres.2021.05.010_bb0480","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.thromres.2020.04.014","article-title":"Severe COVID-19 infection associated with endothelial activation","volume":"190","author":"Escher","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2021.05.010_bb0485","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2021011958","article-title":"Prothrombotic immune thrombocytopenia after COVID-19 vaccine","author":"Tiede","year":"2021","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.thromres.2021.05.010_bb0490","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1182\/blood-2015-06-640995","article-title":"Complement in hemolytic anemia","volume":"126","author":"Brodsky","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2021.05.010_bb0495","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151092","article-title":"Is complement the culprit behind COVID-19 vaccine-related adverse reactions?","author":"Mastellos","year":"2021","journal-title":"J. Clin. Invest."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384821003315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384821003315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:46:45Z","timestamp":1758736005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384821003315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":99,"alternative-id":["S0049384821003315"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2021.05.010","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2021.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}